The Franklin, Tenn.-based hospital chain’s stock price traded as low as $1.92 on Aug. 2 after closing Aug. 1 at $2 per share. During the past year, CHS shares have traded between $1.92 and $5.35.
CHS is slated to release its second-quarter financial results after market close on Aug. 5. The company ended the first quarter of this year with a net loss of $118 million on revenues of $3.38 billion. That’s compared to the first quarter of 2018, when CHS reported a net loss of $25 million on revenues of $3.69 billion.
More articles on healthcare finance:
Texas hospital closes
Struggling New York hospital secures buyer, $20M in funding
Care New England’s financial turnaround continues after calling off merger
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
